These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11847020)

  • 1. [Molecular mechanisms of oncogenic transformation: what's new?].
    Blanchard JM
    Bull Cancer; 2002 Jan; 89(1):9-16. PubMed ID: 11847020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M; Labriola L; Schillaci R; Charreau EH; Elizalde PV
    Exp Cell Res; 2001 Apr; 265(1):152-66. PubMed ID: 11281653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C; Chattopadhyay A; Parkhurst C; Yang E
    Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of D1 and E cyclins in cell cycle progression of human fibroblasts adhering to cementum attachment protein.
    Yokokoji T; Narayanan AS
    J Bone Miner Res; 2001 Jun; 16(6):1062-7. PubMed ID: 11393783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
    Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E
    Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1).
    Perez-Roger I; Kim SH; Griffiths B; Sewing A; Land H
    EMBO J; 1999 Oct; 18(19):5310-20. PubMed ID: 10508164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.
    Damiens E; El Yazidi I; Mazurier J; Duthille I; Spik G; Boilly-Marer Y
    J Cell Biochem; 1999 Sep; 74(3):486-98. PubMed ID: 10412049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role for p27Kip1 in cell cycle arrest after androgen depletion in mouse mammary carcinoma cells (SC-3).
    Menjo M; Kaneko Y; Ogata E; Ikeda K; Nakanishi M
    Oncogene; 1998 Nov; 17(20):2619-27. PubMed ID: 9840925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
    J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
    Said TK; Moraes RC; Singh U; Kittrell FS; Medina D
    Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion-dependent control of cyclin E/cdk2 activity and cell cycle progression in normal cells but not in Ha-ras transformed NRK cells.
    Carstens CP; Krämer A; Fahl WE
    Exp Cell Res; 1996 Nov; 229(1):86-92. PubMed ID: 8940252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ErbB-2 overexpression on mitogenic signalling and cell cycle progression in human breast luminal epithelial cells.
    Timms JF; White SL; O'Hare MJ; Waterfield MD
    Oncogene; 2002 Sep; 21(43):6573-86. PubMed ID: 12242655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
    Khwaja F; Djakiew D
    Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
    Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
    Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathology of the cell cycle in human cancer cells.
    Bártek J; Stasková Z; Draetta G; Lukás J
    Stem Cells; 1993 May; 11 Suppl 1():51-8. PubMed ID: 8318919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of elevated levels of ornithine decarboxylase on cell cycle progression in skin.
    Gilmour SK; Birchler M; Smith MK; Rayca K; Mostochuk J
    Cell Growth Differ; 1999 Nov; 10(11):739-48. PubMed ID: 10593650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
    Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
    Cipriano SC; Chen YQ
    Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
    Fåhraeus R; Laín S; Ball KL; Lane DP
    Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.